UCB Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | UCB

UCB S.A. | Mutual Funds

Mutual Funds that own UCB S.A.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Health Care Fund

11,840,914

6.09%

129,869

2.16%

06/30/2018

Government Pension Fund - Global (The)

2,311,089

1.19%

382,008

0.03%

12/31/2017

Vanguard Total International Stock Index Fund

1,708,515

0.88%

27,915

0.04%

07/31/2018

M&G Global Dividend Fund

1,006,329

0.52%

1.04%

03/29/2018

Schroder ISF - EURO Equity

997,607

0.51%

8,307

1.33%

05/31/2018

Wellington Mgmt. Port (Dublin) Plc - Strategic European Equity

990,000

0.51%

241,000

3.58%

12/31/2017

Oppenheimer International Small Company Fund

982,356

0.51%

0.86%

02/28/2018

Stichting Pensioenfonds ABP (Global Equity Portfolio)

679,963

0.35%

464,124

0.01%

03/31/2018

Vanguard Developed Markets Index Fund

679,756

0.35%

-592

0.06%

07/31/2018

Memnon - European Fund

624,786

0.32%

150,849

8.08%

03/31/2018

About UCB

View Profile

Address	Allée de la Recherche, 60 Brussels BU 1070 Belgium
Employees	-
Website	http://www.ucb.com
Updated	07/08/2019
UCB SA engages in the research, development, and commercialization of pharmaceutical and biotechnology products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.